Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
Open Access
- 1 January 1998
- journal article
- research article
- Published by Elsevier in Current Biology
- Vol. 8 (3) , 125-135
- https://doi.org/10.1016/s0960-9822(98)70059-4
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- VEGF121, a Vascular Endothelial Growth Factor (VEGF) Isoform Lacking Heparin Binding Ability, Requires Cell-surface Heparan Sulfates for Efficient Binding to the VEGF Receptors of Human Melanoma CellsJournal of Biological Chemistry, 1995
- Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfateThe Journal of cell biology, 1993
- Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast DifferentiationScience, 1991
- Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptorCell, 1991
- Signal transduction by receptors with tyrosine kinase activityPublished by Elsevier ,1990
- Molecular cloning and expression of human hepatocyte growth factorNature, 1989
- Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factorBiochemical and Biophysical Research Communications, 1989
- Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement.Proceedings of the National Academy of Sciences, 1989
- Purification and subunit structure of hepatocyte growth factor from rat plateletsFEBS Letters, 1987
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987